Literature DB >> 22954007

Implementation of an enhanced recovery programme following pancreaticoduodenectomy.

Nichola Robertson1, Peter James Gallacher, Natalie Peel, O James Garden, Mark Duxbury, Kristoffer Lassen, Rowan W Parks.   

Abstract

OBJECTIVES: The aim of this prospective study was to investigate the implementation of an enhanced recovery after surgery (ERAS) programme following pancreaticoduodenectomy (PD).
METHODS: Patients undergoing PD were managed according to an ERAS protocol. Outcome measures included postoperative mortality, morbidity, hospitalization and 30-day readmission rate. Key protocol targets were: nasogastric tube (NGT) removal [postoperative day (PoD) 1]; resumption of oral fluids (PoD 1); urinary catheter removal (PoD 3); high-dependency unit (HDU) discharge (PoD 3); tolerating diet (PoD 4); drain removal (PoD 5), and hospital discharge (PoD 6).
RESULTS: Data were collected for 50 patients (24 male; median age 67 years). Rates of mortality, morbidity and readmission were 4%, 46% and 4%, respectively. The median length of postoperative hospitalization was 10 days. The proportions of patients achieving key targets were: 78% for NGT removal; 82% for resumption of oral fluids; 48% for urinary catheter removal; 82% for HDU discharge; 86% for tolerating diet; 84% for meeting mobility targets, and 72% for drain removal. One patient was discharged by PoD 6, eight patients by PoD 7, 15 patients by PoD 8 and 26 patients (52%) by PoD 10. Discharge was delayed in 16 patients for social or transport-related reasons.
CONCLUSIONS: The ERAS protocol was implemented safely. Achieving certain targets was challenging. Non-medical causes remain a significant factor in delayed discharge following PD.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954007      PMCID: PMC3461377          DOI: 10.1111/j.1477-2574.2012.00521.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  54 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; David C Chang; Taylor S Riall; Richard D Schulick; Michael A Choti; JoAnn Coleman; Mary B Hodgin; Patricia K Sauter; Christopher J Sonnenday; Christopher L Wolfgang; Michael R Marohn; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

3.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

Review 5.  Patient controlled intravenous opioid analgesia versus continuous epidural analgesia for pain after intra-abdominal surgery.

Authors:  T Werawatganon; S Charuluxanun
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

6.  Evaluation of surgical outcome scores according to ISGPS definitions in patients undergoing pancreatic resection.

Authors:  B C Knight; A Kausar; M Manu; B A Ammori; D J Sherlock; D A O'Reilly
Journal:  Dig Surg       Date:  2010-10-13       Impact factor: 2.588

7.  Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy.

Authors:  G A Porter; P W Pisters; C Mansyur; A Bisanz; K Reyna; P Stanford; J E Lee; D B Evans
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

8.  Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group.

Authors:  J P Neoptolemos; R C Russell; S Bramhall; B Theis
Journal:  Br J Surg       Date:  1997-10       Impact factor: 6.939

9.  Effect of epidural analgesia on postoperative insulin resistance as evaluated by insulin clamp technique.

Authors:  I Uchida; T Asoh; C Shirasaka; H Tsuji
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

Review 10.  Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis.

Authors:  Daniel M Pöpping; Nadia Elia; Emmanuel Marret; Camille Remy; Martin R Tramèr
Journal:  Arch Surg       Date:  2008-10
View more
  19 in total

1.  Academic Pancreas Centers of Excellence: Guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest.

Authors:  Sunil G Sheth; Darwin L Conwell; David C Whitcomb; Matthew Alsante; Michelle A Anderson; Jamie Barkin; Randall Brand; Gregory A Cote; Steven D Freedman; Andres Gelrud; Fred Gorelick; Linda S Lee; Katherine Morgan; Stephen Pandol; Vikesh K Singh; Dhiraj Yadav; C Mel Wilcox; Phil A Hart
Journal:  Pancreatology       Date:  2017-02-28       Impact factor: 3.996

Review 2.  [Treatment of postoperative impairment of gastrointestinal motility, cholangitis and pancreatitis].

Authors:  T Schulze; C-D Heidecke
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

Review 3.  Systematic review and meta-analysis of enhanced recovery after pancreatic surgery with particular emphasis on pancreaticoduodenectomies.

Authors:  M M E Coolsen; R M van Dam; A A van der Wilt; K Slim; K Lassen; C H C Dejong
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  High performing whipple patients: factors associated with short length of stay after open pancreaticoduodenectomy.

Authors:  Grace C Lee; Zhi Ven Fong; Cristina R Ferrone; Sarah P Thayer; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-del Castillo
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

Review 5.  Enhanced recovery after pancreatic surgery: a systematic review of the evidence.

Authors:  Daniel J Kagedan; Mahrosh Ahmed; Katharine S Devitt; Alice C Wei
Journal:  HPB (Oxford)       Date:  2014-04-18       Impact factor: 3.647

6.  Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy.

Authors:  Jason W Denbo; Morgan Bruno; Whitney Dewhurst; Michael P Kim; Ching-Wei Tzeng; Thomas A Aloia; Jose Soliz; Barbara Bryce Speer; Jeffrey E Lee; Matthew H G Katz
Journal:  Surgery       Date:  2018-05-25       Impact factor: 3.982

7.  Canadian practice patterns for pancreaticoduodenectomy.

Authors:  David P Cyr; Jessica L Truong; Jenny Lam-McCulloch; Sean P Cleary; Paul J Karanicolas
Journal:  Can J Surg       Date:  2015-04       Impact factor: 2.089

8.  Implementation of an Enhanced Recovery Pathway After Pancreaticoduodenectomy in Patients with Low Drain Fluid Amylase.

Authors:  Robert P Sutcliffe; Majd Hamoui; John Isaac; Ravi Marudanayagam; Darius F Mirza; Paolo Muiesan; John K Roberts
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 9.  ERAS and pancreatic surgery: a review.

Authors:  J Perinel; M Adham
Journal:  Updates Surg       Date:  2016-11-02

10.  Improved Outcomes in 394 Pancreatic Cancer Resections: the Impact of Enhanced Recovery Pathway.

Authors:  Vandana Agarwal; Martin Jose Thomas; Riddhi Joshi; Vikram Chaudhari; Manish Bhandare; Abhishek Mitra; Ashwin deSouza; Reshma Ambulkar; Shailesh V Shrikhande
Journal:  J Gastrointest Surg       Date:  2018-05-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.